When can a woman resume or initiate contraception after taking emergency contraceptive pills? A systematic review

Contraception

Volumn 87, Issue 5, 2013, Pages 602-604

  Salcedo, Jennifer ^a   Rodriguez, Maria I ^b   Curtis, Kathryn M ^c   Kapp, Nathalie ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

ECP; Emergency contraception; Levonorgestrel; Ulipristal acetate; Yuzpe method

Indexed keywords

GESTAGEN; MEDROXYPROGESTERONE ACETATE; POSTCOITUS CONTRACEPTIVE AGENT; ULIPRISTAL;

ABSTINENCE; CLINICAL EFFECTIVENESS; CONDOM; EMERGENCY CONTRACEPTION; HORMONAL CONTRACEPTION; HUMAN; MENSTRUAL CYCLE; METRORRHAGIA; PILL; PREGNANCY; REVIEW; SYSTEMATIC REVIEW; UNWANTED PREGNANCY;

CONTRACEPTION, POSTCOITAL; CONTRACEPTIVE AGENTS; FEMALE; HUMANS;

EID: 84876690612     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2012.08.013     Document Type: Review

References (14)

1. E.G. Raymond, A. Goldberg, and J. Trussel Bleeding patterns after use of levonorgestrel emergency contraceptive pills Contraception 73 2006 376 381 (Pubitemid 43375099)
2. World Health Organization Selected practice recommendations for contraception use 2010 World Health Organization Geneva, Switzerland
3. American College of Obstetricians and Gynecologists Practice Bulletin 112: Emergency contraception 2010
4. Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit, Royal College of Obstetricians and Gynaecologists FFPRHC guidance (April 2006) emergency contraception J Fam Plann Reprod Health Care 32 2006 121 128
5. Watson Pharma Inc Prescribing information for Ella 2010 Watson Pharma Inc. Morristown (N.J.)
6. HRA Pharma Advisory Committee for Reproductive Health Drugs Briefing Materials for ulipristal acetate 30 mg tablet June 17, 2010 http://www.fda.gov/ downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ ReproductiveHealthDrugsAdvisoryCommittee/UCM215510.pdf
7. K. Gemzell-Danielsson, and C. Meng Emergency contraception: potential role of ulipristal acetate Int J Women's Health 2 2010 53 61
8. D.L. Blithe, L.K. Nieman, R.P. Blye, P. Stratton, and M. Passaro Development of the selective progesterone receptor modulator CDB-2914 for clinical indications Steroids 68 2003 1013 1017 (Pubitemid 37532426)
9. Duramed Pharmaceuticals, Inc Prescribing information for Plan B One Step. 2009 Duramed Pharmaceuticals, Inc. Pomona (NY)
10. Watson Pharma Inc Prescribing information for Next Choice 2009 Watson Pharma Inc. Morristown (NJ)
11. P. Fine, H. Mathe, S. Ginde, V. Cullins, J. Morfesis, and E. Gainer Ulipristal acetate taken 48-120 hours after intercourse for emergency contraception Obstet Gynecol 115 2010 257 263
12. World Health Organization Medical eligibility criteria 2010 World Health Organization Geneva, Switzerland
13. A. Web, and D. Taverner Clotting factors after emergency contraception Adv Contracept 9 1993 75 82
14. C. Vasilakis, S.S. Jick, and H. Jick The risk of venous thromboembolism in users of postcoital contraceptive pills Contraception 59 1999 79 83 (Pubitemid 29244752)